Navigation Links
NOLabs AB Reports Success in Fight Against Bacteria Causing Urinary Tract Infection
Date:4/15/2008

HELSINGBORG, Sweden, April 15 /PRNewswire/ -- NOLabs AB, the Swedish medtech company focusing on developing innovative Nitric Oxide-containing medical devices, today reported that it has achieved another important milestone in the development of a new preventive therapy against urinary tract infection, UTI.

In experiments performed at the Karolinska University Hospital in Sweden, researchers showed that technology developed by NOLabs AB proved to have a high effectiveness in killing pathogens, typically for those causing UTI including an aggressive strain of E. coli. Millions of patients annually acquire UTI while being hospitalized for treatment of other diseases. Preventing such infection has the potential to dramatically reduce the amount of antibiotics used as well as improving quality of life for a large number of hospitalized patients.

Goran Beijer, CEO of NOLabs says; "We are happy to have taken another important step in developing products that have a huge potential to prevent millions of UTI cases globally every year. The anti-microbial effect of NO will be essential in a range of innovative products that prevent and/or treat infection. We expect to have the first products on the market in early 2009."

Professor Peter Wiklund, Karolinska University says; "This new technology has a huge potential to reduce the usage of Antibiotics and thereby the risk of antibiotic resistance as well as reducing the risk of urosepsis, the severest and potentially lethal consequence of UTI."

NOLabs is developing products that will prevent catheter related urinary tract infections, products that will be effective on reducing neuropathic pain and wound care products with an anti-bacterial effect.

NOLabs is a Swedish bio-medtech company focusing on the development and marketing of Nitric Oxide-containing medical devices for various medical applications. Nitric Oxide is a natural substance, produced by the human body controlling vaso-regu
'/>"/>

SOURCE NOLabs AB
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Spherix Reports Second Quarter Earnings
3. Tapestry Reports Second Quarter 2007 Results
4. Callisto Reports on Second-Quarter 2007 Milestones
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
7. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
8. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
9. Biopure Reports on Meeting with the FDA
10. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
11. NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., LAS ANGELES, December 2 /PRNewswire-FirstC...announced today that it would initiate a programme...informed of the significant,progress which Fountai..., as,well as to provide shareholders with regular ...n Capital Partners and others. , Fountain...
(Date:12/2/2009)... TAMPA, Fla., Dec. 2 Laser Spine ... spinal surgery, is pleased to announce a partner...an extensive six-month negotiation and clinical re... healthcare provider of minimally invasive spinal ...ffective immediately, patients with United Healthc...
(Date:12/2/2009)..., ROYAL OAK, Mich., Dec. 2 ALERT ... company today announced the exclusive availabili...rs. Designed to look like a piece of jewelry, thes...cal function; immediate emergency medical response.../cgi-bin/prnh/20091202/DE19790 ) ,, For elderl...
Breaking Medicine Technology:Fountain Healthy Aging Inc Business Update For Shareholders 2Fountain Healthy Aging Inc Business Update For Shareholders 3Laser Spine Institute Partners with United Healthcare 2Laser Spine Institute Partners with United Healthcare 3Scientists should look at their own carbon footprint 8743 1Scientists should look at their own carbon footprint 8743 2Automated Artificial Pancreas Controls Blood Glucose Levels in Diabetes Patients for First Time 48181 1Automated Artificial Pancreas Controls Blood Glucose Levels in Diabetes Patients for First Time 48181 2Automated Artificial Pancreas Controls Blood Glucose Levels in Diabetes Patients for First Time 48181 3Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 1Quest Diagnostics to Speak at the William Blair 26 Company 29th Annual Growth Stock Conference 48179 2
...19 Results from a Phase III,clinical trial evalua...,once monthly for the treatment of postmenopausal ...y for Bone and Mineral Research (ASBMR),29th Annua...risedronate 150,mg once monthly to risedronate 5 m...increases in bone mineral density (BMD) were simil...
.... 18 A long-term study found,that a type of stem ...ening,diseases, such as leukemia and lymphoma, res... recipients. Further, males are likely to recover,...of female patients,remains compromised. In additio...ors regained levels of sexual activity and functio...
Other Medicine Technology:New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 2New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 3New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 4New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 5New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis 6Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 2Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 3Sexual Function Affected by Stem Cell Transplant According to Long-Term Study 4
(Date:12/2/2009)...GINIA BEACH, Va., Dec. 2 By now, m...okeless cigarettes continue to grow in popularity....lable at the PremiumEcigarette - the new single pi... - at the amazingly low price of $14.99. ,, "Th... the e-cigarette at a very low price, before makin...
(Date:12/2/2009)... , New Directors Represent Diverse Healthc...wswire-USNewswire/ -- The membership of the Nation... its Board of Directors and reappointed four curre...a wide range of healthcare stakeholders, including...nd public and community healthcare. ,, The new...
(Date:12/2/2009)...LADELPHIA, Dec. 2 Independence Blu...its contract with Lincoln Financial Group. IBC wil...approximately 10,000 Lincoln Financial Group emplo...tion. The Lincoln plan offerings will include the ...,, "I know I speak for all of us at Independenc...
(Date:12/2/2009)...lif.Researchers from the California Institute of T...il, and for the first time, the previously mysteri...ed ubiquitin are added by enzymes called ubiquitin...Ubiquitin chains tag target proteins for destructi... "We found that ubiquitin ligases build ubiquitin ...
(Date:12/2/2009)...is the official congress of the European Associati...of the European Society of Cardiology, where techn...resented. , New case reports will be presented ...highlighting the role of this new technology. , ...iques, it is likely that non-invasive imaging will...
Breaking Medicine News(10 mins):Health News:A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product 2Health News:National Quality Forum Members Elect Nine Directors to Board 2Health News:National Quality Forum Members Elect Nine Directors to Board 3Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 2Health News:Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 2Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 3Health News:Caltech scientists show how ubiquitin chains are added to cell-cycle proteins 4Health News:Media alert: EUROECHO 2009 2
... ATS Medical, Inc.,(Nasdaq: ATSI ), manufacturer ...roducts and services, today announced that it will...nded September 27, 2008 after the,market close on ... Time) to discuss its second quarter results,and c...
...28 Professional Healthcare,Resources, Inc., one o...healthcare agencies based in the Washington, DC me...been named to the 2008 Homecare Elite. The,selecti...ealthcare publisher., This annual review identifi...
...ialty Pharmacy programs expand URAC,s Pharmacy,Qua...28 URAC announced that four,companies have achiev...ograms under its Pharmacy Quality Management(SM) i...his scope for the pharmacy benefit management and ...
...tion in BRCA1 Mutation Carriers , One X chromoso...romosome in women who carry mutations in the BRCA1... with a later onset of breast or ovarian cancer in...X chromosome, the cells in a woman,s body inactiva...
...-lowering statins is associated with a statistical...n (PSA) levels, according to a report in the Octob... Cancer Institute . , Previous studies examined w... association between statins and PSA level. , In...
...patients in more than 1,500 physician practices ha...ealth-care experiences, with minority patients hav...dings suggest that while all doctors should be att...nt-centered. The study, which was led by a health ...
Other Medicine News:Health News:ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call 2Health News:Professional Healthcare Ranked Among the Top 25 Percent of Home Health Care Providers in the Country for 2008 2Health News:Professional Healthcare Ranked Among the Top 25 Percent of Home Health Care Providers in the Country for 2008 3Health News:Four Companies Are First to Achieve Accreditation Under Two New URAC Pharmacy Quality Management(SM) Programs 2Health News:Also in the Oct. 28 JNCI 2Health News:Also in the Oct. 28 JNCI 3Health News:Also in the Oct. 28 JNCI 4Health News:Also in the Oct. 28 JNCI 5Health News:Statin use associated with reduction in prostate specific antigen levels 2Health News:Racial and ethnic disparities detected in patient experiences 2
Snap-In Snap-Out®-II Alligator Grasping Forceps Insert
Snap-In Snap-Out®-II Strong Grasping Forceps Insert
Optima III 45 Noninsulated Maryland Dissector
Dolphin-Nose Dissector, dual-incision
Medicine Products: